Goldman Sachs Exposes the Cure Dilemma

Goldman Sachs Exposes the Cure Dilemma

Story Highlights New gene therapies offer unprecedented hope for permanent cures of serious diseases and hold the promise of an invaluable societal impact. In a report to their biotech clients, investment giant Goldman Sachs questions whether curative therapies are a viable business model. Using Gilead Science’s hepatitis C drug as an example, the report noted […]